An open-label, randomised, single and repeat dose parallel group Phase I study to evaluate the pharmacokinetics of ST10 at three dosage levels in subjects with iron deficiency (with or without anaemia).
Phase of Trial: Phase I
Latest Information Update: 12 Apr 2016
Price : $35 *
At a glance
- Drugs Ferric maltol (Primary)
- Indications Iron deficiency anaemia
- Focus Biomarker; Pharmacokinetics
- Sponsors Iron Therapeutics
- 12 Apr 2016 Results published in the European Journal of Drug Metabolism and Pharmacokinetics
- 27 Sep 2014 Status changed from recruiting to completed as reported by EudraCT record.
- 06 May 2014 New trial record